A detailed history of State Street Corp transactions in Zai Lab LTD stock. As of the latest transaction made, State Street Corp holds 636,732 shares of ZLAB stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
636,732
Previous 659,805 3.5%
Holding current value
$11 Million
Previous $18 Million 43.43%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$15.95 - $26.8 $368,014 - $618,356
-23,073 Reduced 3.5%
636,732 $10.2 Million
Q4 2023

Feb 14, 2024

BUY
$22.97 - $30.58 $295,026 - $392,769
12,844 Added 1.99%
659,805 $18 Million
Q3 2023

Nov 14, 2023

SELL
$22.72 - $31.49 $517,516 - $717,279
-22,778 Reduced 3.4%
646,961 $15.7 Million
Q2 2023

Aug 14, 2023

SELL
$25.3 - $39.67 $15.6 Million - $24.4 Million
-616,150 Reduced 47.92%
669,739 $18.6 Million
Q1 2023

May 15, 2023

SELL
$30.21 - $48.1 $7.5 Million - $11.9 Million
-248,358 Reduced 16.19%
1,285,889 $42.8 Million
Q4 2022

Feb 14, 2023

BUY
$22.28 - $38.71 $5,079 - $8,825
228 Added 0.01%
1,534,247 $47.1 Million
Q3 2022

Nov 15, 2022

BUY
$34.2 - $51.69 $2.43 Million - $3.67 Million
71,056 Added 4.86%
1,534,019 $52.5 Million
Q2 2022

Aug 15, 2022

BUY
$23.14 - $49.68 $840,282 - $1.8 Million
36,313 Added 2.55%
1,462,963 $50.7 Million
Q1 2022

May 16, 2022

SELL
$27.77 - $64.4 $4.04 Million - $9.36 Million
-145,390 Reduced 9.25%
1,426,650 $62.7 Million
Q4 2021

Feb 14, 2022

BUY
$54.9 - $105.21 $4.04 Million - $7.74 Million
73,522 Added 4.91%
1,572,040 $98.8 Million
Q3 2021

Nov 15, 2021

BUY
$105.0 - $178.37 $5.25 Million - $8.92 Million
50,013 Added 3.45%
1,498,518 $158 Million
Q2 2021

Aug 16, 2021

BUY
$125.11 - $180.0 $8.78 Million - $12.6 Million
70,214 Added 5.09%
1,448,505 $256 Million
Q1 2021

May 17, 2021

BUY
$126.27 - $191.71 $18.4 Million - $27.9 Million
145,644 Added 11.82%
1,378,291 $184 Million
Q4 2020

Feb 16, 2021

BUY
$81.94 - $135.34 $14.4 Million - $23.7 Million
175,406 Added 16.59%
1,232,647 $167 Million
Q3 2020

Nov 10, 2020

BUY
$73.3 - $89.48 $12.7 Million - $15.5 Million
173,296 Added 19.6%
1,057,241 $87.9 Million
Q2 2020

Aug 14, 2020

BUY
$48.82 - $82.53 $10.8 Million - $18.3 Million
222,158 Added 33.57%
883,945 $72.6 Million
Q1 2020

May 11, 2020

BUY
$39.1 - $62.9 $25.9 Million - $41.6 Million
661,787 New
661,787 $34.1 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $1.7B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.